Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megestrol acetate for weight loss in severe chronic obstructive pulmonary disease
2005-005148-16Phase 4Active
- Sponsor
- Madaus GmbH
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Megestrol acetate with Placebo (2 arms). Primary endpoints: Body weight change and Body mass index change. Started Jan 2006; status: active.
02
Drugs
megestrol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2005-005148-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005148-16.